ANTI-ACRP30
- $503 - $544
- Product name: ANTI-ACRP30
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:MFCD03454695
- Synonyms:MONOCLONAL ANTIBODY TO ACRP30 (HUMAN) (AX741);MONOCLONAL ANTIBODY TO ACRP30 (HUMAN) (AX773);MONOCLONAL ANTIBODY TO ACRP30 (HUMAN) (NE NA);ANTI-HUMAN APM1;ANTI-HUMAN GBP28;ANTI-ADIPOCYTE COMPLEMENT-RELATED PROTEIN OF 30 KDA;ANTI-ADIPOCYTE COMPLEMENT RELATED PROTEIN OF 30 KDA (ACRP30);ANTI-ADIPOCYTE COMPLEMENT RELATED PROTEIN OF 30KDA (HUMAN)
3 prices
Selected condition:
Brand
- Sigma-Aldrich
Package
- 100μg
- 200μL
- ManufacturerSigma-Aldrich
- Product numberA6354
- Product descriptionAnti-Adiponectin antibody produced in rabbit ~1?mg/mL, affinity isolated antibody, buffered aqueous solution
- Packaging200μL
- Price$544
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberPRS3551
- Product descriptionAnti-Adiponectin (ab1) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution
- Packaging100μg
- Price$524
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberPRS3553
- Product descriptionAnti-Adiponectin (ab2) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution
- Packaging100μG
- Price$503
- Updated2023-06-20
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich | A6354 | Anti-Adiponectin antibody produced in rabbit ~1?mg/mL, affinity isolated antibody, buffered aqueous solution | 200μL | $544 | 2024-03-01 | Buy |
Sigma-Aldrich | PRS3551 | Anti-Adiponectin (ab1) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution | 100μg | $524 | 2024-03-01 | Buy |
Sigma-Aldrich | PRS3553 | Anti-Adiponectin (ab2) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution | 100μG | $503 | 2023-06-20 | Buy |
Properties
storage temp. :−20°C
form :buffered aqueous solution
form :buffered aqueous solution
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|